Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Jeremy Rodrigues who has been awarded an NIHR Postdoctoral Fellowship for a project entitled “Improving treatment decision making in hand surgery”. This aims to understand the variation in Dupuytren’s disease intervention in the NHS and to improve decision making in treatments.

Dupuytren’s disease affects up to 1 in 10 people in Britain, and is currently treated in a variety of ways including injections and surgery. Patient-Reported Outcome Measures (PROMs) are already captured nationally but there is scope to improve them, and to better use the data generated.

Jeremy’s work will examine existing PROMs, understand why patients and surgeons choose treatments, and study the effect of treatment.  The findings will be combined in a decision support package to guide treatment choice.

Commenting on his award,  Jeremy stated “I am grateful to NIHR and the British Society for Surgery of the Hand for supporting this project and my further training.  This award reflects the wide-ranging academic and clinical support that I receive in Oxford and Thames Valley.  I am excited about starting the fellowship, which I believe will contribute to improved care for people with a common hand condition.”

FUNDING BODY

NIHR NHS_Logo_Funded by Stamp.jpg

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.